posted on 2021-03-18, 04:38authored byP. Trevisi, D. Luise, F. Correa, S. Messori, M. Mazzoni, J. P. Lallès, P. Bosi
Additional file 1: Supplemental Table 1. Primers information and real-time quantitative PCR conditions used in the trial. Supplemental Table 2. Characteristics of antibodies used for immunostaining.